SEC Form 4 · accession 0001654954-18-011701
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Camber Capital Management LP
10% Owner
Period of report
Oct 29, 2018
Accepted (ET)
Oct 30, 2018 · 11:46 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 9,300,000 | I | See Footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Due to an increase in the number of outstanding shares of common stock of the Issuer, the Reporting Person no longer beneficially owns more than 10% of the Issuer's common stock and is no longer subject to Section 16